Hospital · Private company
Seattle Children's Hospital
Track this companyFree. Adds Seattle Children's Hospital to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- A Study of CLEC2A CAR T for Pediatric and Adult Patients With Relapsed or Refractory AMLPHASE1 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07905027 · fetched Nov 12, 2026
- Automatic Versus As-Needed Follow-up After Hospitalization for Children With Medical ComplexityNA · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07864636 · fetched Nov 12, 2026
- Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy ProductsRECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07424157 · fetched Nov 12, 2026
- A Vaccine Communication Training Intervention for Pediatric Inpatient CliniciansNA · NOT_YET_RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT07552857 · fetched Nov 12, 2026
- Familial Inflammatory Bowel Disease Early RiskRECRUITING · started Mar 26, 2026ClinicalTrials.gov NCT07791862 · fetched Nov 12, 2026
- I-DECIDE After Bronchiolitis HospitalizationNA · RECRUITING · started Nov 1, 2025ClinicalTrials.gov NCT07243652 · fetched Nov 12, 2026
- Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic ObesityPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 1, 2025ClinicalTrials.gov NCT06299891 · fetched Nov 12, 2026
- The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With CancerNA · ACTIVE_NOT_RECRUITING · started May 15, 2024ClinicalTrials.gov NCT06242964 · fetched Nov 12, 2026
- Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)RECRUITING · started May 10, 2024ClinicalTrials.gov NCT06315179 · fetched Nov 12, 2026
- Family Bridge ProgramNA · ENROLLING_BY_INVITATION · started May 7, 2024ClinicalTrials.gov NCT06276621 · fetched Nov 12, 2026
- Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis PainNA · RECRUITING · started May 1, 2024ClinicalTrials.gov NCT06386224 · fetched Nov 12, 2026
- Resilience Mobile App for Teens and Young Adults With CancerNA · RECRUITING · started Sep 12, 2023ClinicalTrials.gov NCT05842902 · fetched Nov 12, 2026
- Comparing a Team-Based Approach to Standard Well-Child Visits To Improve Preventive Care ServicesNA · RECRUITING · started Jun 30, 2023ClinicalTrials.gov NCT05852392 · fetched Nov 12, 2026
- The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal PathologiesNA · RECRUITING · started Jun 9, 2023ClinicalTrials.gov NCT06072976 · fetched Nov 12, 2026
- Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started May 5, 2023ClinicalTrials.gov NCT05768880 · fetched Nov 12, 2026
- Using Shared Decision Making to Improve Family Media Use PlanningNA · RECRUITING · started Jul 10, 2022ClinicalTrials.gov NCT05722535 · fetched Nov 12, 2026
- A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic SarcomaPHASE1 · ACTIVE_NOT_RECRUITING · started May 20, 2022ClinicalTrials.gov NCT05312411 · fetched Nov 12, 2026
- A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or LymphomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 25, 2020ClinicalTrials.gov NCT04571138 · fetched Nov 12, 2026
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 13, 2020ClinicalTrials.gov NCT04483778 · fetched Nov 12, 2026
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 18, 2019ClinicalTrials.gov NCT03618381 · fetched Nov 12, 2026
- CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or LymphomaPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 28, 2018ClinicalTrials.gov NCT03684889 · fetched Nov 12, 2026
- Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ LeukemiaPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 4, 2017ClinicalTrials.gov NCT03186118 · fetched Nov 12, 2026
- Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01PHASE1 · ACTIVE_NOT_RECRUITING · started Nov 25, 2014ClinicalTrials.gov NCT02311621 · fetched Nov 12, 2026
- A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ LeukemiaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 11, 2014ClinicalTrials.gov NCT02028455 · fetched Nov 12, 2026
- A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic LeukemiaPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 25, 2012ClinicalTrials.gov NCT01683279 · fetched Nov 12, 2026